← Leaderboards
Fernando Holguin
University Of Pittsburgh At Pittsburgh
$10,342,142
Attributed
$23,184,398
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,184,398 · 9
By mechanism
R01$15,168,572 · 5
U10$4,675,261 · 1
R33$2,285,261 · 1
R61$741,557 · 1
R24$313,747 · 1
Top collaborators
- Sally E Wenzel7 shared
- Hong W Chu5 shared
- Jane Ellen Clougherty5 shared
- Loretta G Que5 shared
- Max A Seibold5 shared
- Alex D. Federman4 shared
- Bruce A Freeman4 shared
- Stacy Lynn Gelhaus4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Francisco Jose Schopfer$8,044,712
- Alison Morris$31,399,077
- Erick Forno$4,213,560
- Jessica Bon$4,678,630
- Soma Jobbagy$195,264
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaInflammationPharmaceutical PreparationsAsthmaticObesityMediatingAdultPhenotypeEnzymesResponseInflammatoryNitric OxideClinical TrialsPrimary OutcomeSecondary OutcomeBronchodilator AgentsAdrenal Cortex HormonesPathway InteractionsDesignQuality Of LifeTranslational ResearchIncidenceImpairmentAirway Inflammation
Grant awards (35)
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$759,073
R33 · FY2025 · HL · contact PI
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$752,287
R33 · FY2024 · HL · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$712,997
R01 · FY2024 · AI
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$773,901
R33 · FY2023 · HL · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$718,437
R01 · FY2023 · AI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$700,666
R01 · FY2023 · HL · contact PI
LIMA: Lipid anti-Inflammatory Mediators in Asthma to reduce airway hyperresponsiveness in obese asthmatics$741,557
R61 · FY2022 · HL · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$729,236
R01 · FY2022 · AI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$701,814
R01 · FY2022 · HL · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$731,404
R01 · FY2021 · AI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$702,231
R01 · FY2021 · HL · contact PI
Parkin in mitochondrial dysfunction and airway inflammation of obese asthma$771,182
R01 · FY2020 · AI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$745,579
R01 · FY2020 · HL · contact PI
SANDIA: Supplementing L-citrulline to overweight late Asthma oNset phenotypes to increase airway L-arginine/ADMA ratio and Improve Asthma control$779,232
R01 · FY2019 · HL · contact PI
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways$768,206
R01 · FY2019 · HL
Anti-Inflammatory Lipid Mediators in Asthma$743,388
R01 · FY2019 · HL
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways$768,909
R01 · FY2018 · HL
Anti-Inflammatory Lipid Mediators in Asthma$737,737
R01 · FY2018 · HL
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways$803,655
R01 · FY2017 · HL
Anti-Inflammatory Lipid Mediators in Asthma$720,022
R01 · FY2017 · HL
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways$811,297
R01 · FY2016 · HL
Anti-Inflammatory Lipid Mediators in Asthma$694,959
R01 · FY2016 · HL
Validating GIS-based methods to address spatial uncertainty in clinical trials$371,273
R01 · FY2016 · HL
Validating GIS-based methods to address spatial uncertainty in clinical trials$365,918
R01 · FY2015 · HL
Healthy Learning, Healthy Living Healthy Lives$313,747
R24 · FY2015 · MD
AsthmaNet: Phenotypic Influences on Asthma Treatments$253,408
U10 · FY2015 · HL
AsthmaNet: Phenotypic Influences on Asthma Treatments$494,957
U10 · FY2014 · HL
Validating GIS-based methods to address spatial uncertainty in clinical trials$364,267
R01 · FY2014 · HL
AsthmaNet: Phenotypic Influences on Asthma Treatments$849,636
U10 · FY2013 · HL
Validating GIS-based methods to address spatial uncertainty in clinical trials$354,056
R01 · FY2013 · HL
AsthmaNet: Phenotypic Influences on Asthma Treatments$852,487
U10 · FY2012 · HL
Validating GIS-based methods to address spatial uncertainty in clinical trials$372,107
R01 · FY2012 · HL
AsthmaNet: Phenotypic Influences on Asthma Treatments$857,131
U10 · FY2011 · HL
AsthmaNet: Phenotypic Influences on Asthma Treatments$838,101
U10 · FY2010 · HL
AsthmaNet: Phenotypic Influences on Asthma Treatments$529,541
U10 · FY2009 · HL